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ABSTRACT 
The present study was set up to investigate the effects of Trichostatin A (TSA), a prototypical epigenetic modifi-
er, on the expression and activity of hepatic drug uptake transporters in primary cultured rat hepatocytes. To this 
end, the expression of the sinusoidal transporters sodium-dependent taurocholate cotransporting polypeptide 
(Ntcp) and organic anion transporting polypeptide 4 (Oatp4) was monitored by real-time quantitative reverse 
transcriptase polymerase chain reaction analysis and immunoblotting. The activity of the uptake transporters was 
analyzed using radiolabeled substrates and chemical inhibitors. Downregulation of the expression and activity of 
Oatp4 and Ntcp was observed as a function of the cultivation time and could not be counteracted by TSA. In 
conclusion, the epigenetic modifier TSA does not seem to exert a positive effect on the expression and activity of 
the investigated uptake transporters in primary rat hepatocyte cultures. 
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Abbreviations: ABC, ATP binding cassette; B2m, beta-2 microglobulin; BSA, bovine serum albumin; DNA, 
complementary deoxyribonucleic acid; DNMT, DNA methyltransferase; DMSO, dimethylsulfoxide; Gapdh, 
glyceraldehyde-3-phosphate dehydrogenase; HDAC, histone deacetylase; Hnf-1α, hepatocyte nuclear factor-1α; 
Hmbs, hydroxymethylbilane synthase; (m)RNA, (messenger)ribonucleic acid; Ntcp, sodium-dependent tau-
rocholate cotransporting polypeptide; Oatp4, organic anion transporting polypeptide 4; PBS, phosphate buffered 
saline; RT-qPCR, real-time quantitative reverse transcriptase polymerase chain reaction; SLC, solute carrier; 
TBS-T, Tris-buffered saline solution; TSA, Trichostatin A; Ubc, ubiquitin C. 
 
 
 
 
INTRODUCTION 
Over the years, numerous animal studies 
have been carried out to determine the phar-
maco-toxicological properties of new chemi-
cal entities. However, their use has been 
strongly criticized and with the introduction 
of the 3Rs concept of Russell and Burch in 
1959, more attention has been paid to the es-
tablishment of alternative in vitro models 
(EMA, 2011, 1997; Flecknell, 2002; May et 
al., 2009). Among the variety of liver-based 
in vitro models available today, cultures of 
primary hepatocytes are generally considered 
as the gold standard. Indeed, in these cells, 
the entire spectrum of biotransformation en-
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zymes and drug transporters involved in he-
patic drug clearance is expressed at an in vi-
vo-like level, rendering this in vitro setting 
an excellent tool to evaluate drug metabo-
lism and to predict drug-induced liver toxici-
ty (Hewitt et al., 2007; Ramboer et al., 2013; 
Ulvestad et al., 2011; Vinken et al., 2012). 
However, primary hepatocyte cultures cope 
with dedifferentiation, which also negatively 
affects drug transporter expression (Jigorel et 
al., 2005; Luttringer et al., 2002; Rippin et 
al., 2001). Accordingly, considerable focus 
has been put on the development of strate-
gies to counteract this deteriorative process, 
in particular by mimicking the in vivo hepat-
ic micro-environment (Hewitt et al., 2007; 
Papeleu et al., 2002). Cultivating rat hepato-
cytes between 2 layers of gelled collagen 
(i.e. sandwich configuration) has been re-
ported to lead to a better retention of drug 
transporter expression (Liu et al., 1998) and 
support the reestablishment of the canalicu-
lar network and proper localization of cana-
licular transporters, making this in vitro 
model often the reference system to study 
hepatobiliary transport (Ramboer et al., 
2013). However, in this in vitro model the 
expression and functionality of the drug up-
take transporters are usually still considera-
bly decreased in function of culture time (Ja-
cobsen et al., 2011; JØrgensen et al., 2007; 
Kotani et al., 2011; Tchaparian et al., 2011). 
Since these conventional strategies do not 
tackle the actual causes of dedifferentiation, 
new approaches that affect dedifferentiation 
at the most upstream level of its regulation 
could thereby more effectively impact this 
process. In this respect, epigenetic modifica-
tion of hepatocellular gene expression by 
histone deacetylase (HDAC) inhibitors, with 
Trichostatin A (TSA) as a prototype, can 
strongly favour the differentiated phenotype 
in primary rat hepatocyte cultures, including 
boosting of functional expression of phase I 
biotransformation enzymes (Henkens et al., 
2007). Yet, no information regarding the ef-
fect of HDAC inhibition on drug transporter 
expression and functionality in primary 
hepatocyte cultures is available. Indeed, re-
ports on the epigenetic regulation of drug 
transporter proteins are limited and mainly 
restricted to cancer research (Klaassen et al., 
2011). Nevertheless, it has been repeatedly 
demonstrated that in mice, epigenetic mech-
anisms, namely DNA methylation and/ or 
histone acetylation, are involved in liver-
specific expression of drug transporters 
(Douet et al., 2007; Imai et al., 2009, 2013). 
The latter are specialized transmembrane 
proteins that belong either to the solute carri-
er (SLC) superfamily or to the ATP binding 
cassette (ABC) superfamily (Li et al., 2009; 
Russel, 2010; Shugarts and Benet, 2009; 
Thompson, 2011; Zhang et al., 2006). SLC 
superfamily members, such as the organic 
anion transporting polypeptide 4 (Oatp4) and 
the sodium taurocholate cotransporting poly-
peptide (Ntcp), as well as their ABC coun-
terparts, are frequently involved in drug-drug 
interactions and drug-induced toxicities 
(Giacomini et al., 2010; Kato et al., 2002; 
Thompson, 2011; Zhang et al., 2006). 
Hence, drug transporter research is nowa-
days routinely implemented in safety and ef-
ficacy assessment during the drug develop-
ment process. This research area, at least in 
part, typically relies on in vitro experimenta-
tion (Ramboer et al., 2013). The current 
study was set up to investigate whether epi-
genetic modification also affects the expres-
sion and functionality of drug uptake trans-
porters in vitro and the TSA-optimized pri-
mary hepatocyte cultures could represent a 
user-friendly alternative for the labour-
intensive “sandwich” cultures for transporter 
research.  
 
MATERIALS AND METHODS 
Chemicals and reagents 
TSA was supplied by Errant Gene Thera-
peutics (United States of America). The ra-
diolabeled compounds ([3H] taurocholic acid 
(specific activity 5 Ci/mmol), [3H] estrone-
3-sulfate (specific activity 45.6 Ci/mmol), 
scintillation vials and scintillation fluid (Ul-
tima Gold MV) were purchased from Perkin 
Elmer (Belgium). All other chemicals were 
commercially available products of analyti-
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cal grade and were obtained from Sigma 
(Belgium), unless specified otherwise. Pro-
benecid and TSA were dissolved in dime-
thylsulfoxide (DMSO), with final DMSO 
concentrations not exceeding 1 % v/v. 
 
Hepatocyte isolation and cultivation 
Procedures for the housing of rats as well 
as for the isolation and cultivation of hepato-
cytes were approved by the local Ethical 
Committee of the Vrije Universiteit Brussel 
(Belgium). Male outbred Sprague-Dawley 
rats, weighing 250-275 g (Charles River La-
boratories, France) were kept under control-
led environmental conditions with free ac-
cess to food and water. Hepatocytes were 
isolated by use of a 2-step collagenase meth-
od (Papeleu et al., 2006). Viable (≥ 85 %) 
hepatocytes were seeded on a plastic surface 
at a density of 0.57 x 105 cells/cm2 (6-well 
plates - 9.6 cm2) or 0.82 x 105 cells/cm2 
(6 cm dish - 19.5 cm2) in William’s medium 
E (Invitrogen, Belgium) supplemented with 
7 ng/ml glucagon, 292 mg/ml L-glutamine, 
antibiotics (7.33 I.E./ml sodium benzyl peni-
cillin, 50 µg/ml kanamycin monosulphate, 
10 µg/ml sodium ampicillin, 50 µg/ml strep-
tomycin sulphate) and 10 % v/v fetal bovine 
serum (Gibco, Belgium). Cell culture plates 
were placed in an incubator (37 °C, 5 % 
CO2) and after 4 hours, cell culture media 
were removed and replaced by serum-free 
medium supplemented with 25 µg/ml hydro-
cortisone sodium hemisuccinate and 0.5 µg/ 
ml insulin. All hepatocyte cultures were 
maintained in an incubator (37 °C, 5 % CO2) 
and cell culture media were replaced daily. 
The cultivation conditions used were as fol-
lows: monolayer cultures either exposed to  
(i) 25 µM TSA or  
(ii) 0.083 % v/v DMSO (solvent control), or  
(iii) untreated monolayer cultures.  
Samples were taken 4 hours after plating 
(T4) and on day 4 (D4) of the cultivation pe-
riod. 
 
Real-time quantitative reverse transcriptase 
polymerase chain reaction (RT-qPCR) 
analysis 
Cells were harvested by scraping, 
washed with ice-cold phosphate buffered sa-
line (PBS) and pelleted. Total cellular ribo-
nucleic acid (RNA) extraction, complemen-
tary deoxyribonucleic acid (cDNA) produc-
tion and cDNA purification were carried out 
as outlined elsewhere (De Kock et al., 2012). 
The RT-qPCR reaction mix and RT-qPCR 
conditions, using the StepOnePlus system 
(Applied Biosystems, Belgium), were estab-
lished according to the manufacturer’s in-
structions (Applied Biosystems, Belgium). 
Gene mixes were purchased form Applied 
Biosystems (Table 1). Selection of reliable 
housekeeping genes for normalization of the 
RT-qPCR data was done using qbasePLUS 
software (Biogazelle, Belgium), whereby be-
ta-2 microglobulin (B2m), ubiquitin C 
(Ubc), hydroxymethylbilane synthase 
(Hmbs) and glyceraldehyde-3-phosphate de-
hydrogenase (Gapdh) were selected as the 
most stable housekeeping genes (results not 
shown). The results were processed accord-
ing to the 2-ΔΔCT method (Livak and 
Schmittgen, 2001) and relative messenger 
RNA (mRNA) expression levels of each 
drug transporter were expressed as fold 
changes normalized against the geometric 
means of all 4 housekeeping gene mRNAs 
and scaled against the mRNA expression 
level of T4 untreated monolayer cultures, ar-
bitrarily set at 100 %.  
 
Table 1: Gene expression assays used for qRT-
PCR 
Gene Assay ID Accession number 
Ntcp (Slc10a1) Rn00566894_m1 NM_017047.1
Oatp4 (Slco1b2) Rn01492634_m1 NM_031650.2
Gapdh Rn01775763_g1 NM_017008.3
Ubc Rn01789812_g1 NM_017314.1
Hmbs Rn00565886_m1 NM_013168.2
B2m Rn00560865_m1 NM_012512.2
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Western blot analysis 
Cells were harvested by scraping, 
washed with ice-cold PBS and pelleted. To-
tal cellular protein extraction was performed 
as described elsewhere (Vinken et al., 2011) 
and quantification was carried out according 
to the Bradford procedure using bovine se-
rum albumin (BSA) as a standard (Bradford, 
1976). Proteins (50 μg) were heated, frac-
tionated on sodium dodecyl sulphate poly-
acrylamide (7.5 % or 10 % w/v) and blotted 
afterwards onto nitrocellulose membranes 
(Amersham, United Kingdom) (Ntcp) or po-
lyvinylidene difluoride membranes (Bio-
Rad, Germany) (Oatp4). For Ntcp the subse-
quent steps were performed using the Super-
signal Western Blot Enhancer kit (Pierce, 
Belgium). Membranes were blocked with 
5 % w/v non-fatty milk in Tris-buffered sa-
line solution (20 mM tris(hydroxymethyl) 
amino, 135 mM NaCl) containing 0.1 % v/v 
Tween 20 (TBS-T). Membranes were incu-
bated overnight at 4 °C with primary anti-
bodies directed against a specific drug trans-
porter (Table 2), followed by incubation for 
1 hour at room temperature with a horserad-
ish peroxidase-conjugated secondary anti-
body (Dako, Denmark). Excess antibody was 
removed by washing the membranes several 
times with TBS-T. Detection of the proteins 
was carried out by means of an enhanced 
chemiluminescence Western blotting system 
(Pierce, Belgium). For semi-quantification of 
the results, blots were further incubated with 
a primary antibody against hepatocyte nucle-
ar factor-1α (Hnf-1α) (Table 2), which was 
previously identified as a robust housekeep-
ing protein in primary rat hepatocyte cultures 
(Henkens et al., 2007). Blots were scanned 
and densitometric analyses were performed 
by using the Quantity One software (Bio-
Rad, Germany). Transporter signals were 
normalized against the corresponding Hnf-1α 
signals and were expressed as percentage of 
the normalized transporter signals in T4 un-
treated monolayer cultures, arbitrarily set at 
100 %. 
 
Sinusoidal uptake assay 
Cell culture medium was removed and 
cells were washed twice and incubated for 10 
minutes with transporter assay buffer at 
37 °C [5.3 mM KCl, 1.1 mM KH2PO4, 0.8 
mM MgSO4, 1.8 mM CaCl2, 11 mM D-
glucose, 10 mM HEPES, and 136 mM N-
methyl glucamine (sodium-free buffer) or 
136 mM NaCl (sodium-containing buffer)] 
(Jigorel et al., 2005). To study the activity of 
Ntcp and Oatp4, cells were incubated with 
transporter uptake buffer at 37 °C supple-
mented with the radiolabeled substrates (1 
µCi/ml) [3H] taurocholic acid (0.2 µM) 
(Ntcp) and [3H] estrone-3-sulfate (0.02 µM) 
(Oatp4) either in the presence or absence of 
their inhibitors, namely sodium ions (Ntcp) 
and probenecid (1 mM) (Oatp4), respective-
ly. Uptake was stopped by addition of ice-
cold PBS containing 0.2 % w/v BSA (Poirier 
et al., 2008). After a final washing step with 
ice-cold PBS, cells were lyzed with mamma-
lian protein extraction reagent (Pierce, Bel-
gium) and the intracellular accumulation of 
the radiolabeled substrate was measured us-
ing liquid scintillation counting (Tri-Carb, 
Perkin Elmer, Belgium). The total protein 
content from each well was determined by 
means of the Bradford method (Bradford, 
1976) with BSA as a standard and was used 
to normalize uptake activity. Passive 
transport was determined by performing ex-
periments at 4 °C using cold substrate solu-
tions (Poirier et al., 2008). The difference in 
intracellular radioactive accumulation in the 
absence and presence of the respective inhib-
itors was considered to represent the trans-
porter activity (Jigorel et al., 2005).  
 
Statistical analysis 
Data are expressed as mean ± standard 
deviation of at least 3 independent experi-
ments. Results were evaluated using a one-
tailed or 2-tailed paired Student’s t-test with 
level of significance p ≤ 0.05. In order to de-
termine changes in function of the cultiva-
tion time, the expression and activity of 
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Table 2: Primary antibodies used for Western blot analysis 
Antigen Supplier Reference Species Type Dilution 
Ntcp Santa Cruz sc-107032 Goat Polyclonal 1/1500 
Oatp4 Santa Cruz sc-134461 Rabbit Polyclonal 1/2500 
Hnf-1α Santa Cruz sc-10791 Rabbit Polyclonal 1/1000 
 
 
transporters in T4 and D4 untreated mono-
layer cultures were analyzed. The effect re-
lated to the addition of DMSO or TSA to the 
culture medium was studied at each 
timepoint by comparing the results obtained 
in solvens control with untreated monolayers 
or TSA-treated hepatocytes with solvens 
control, respectively.  
 
RESULTS 
The effect of TSA on the mRNA expression 
of drug uptake transporters in primary rat 
hepatocyte cultures 
Previous research showed that in primary 
rat hepatocyte cultures 25 µM TSA positive-
ly affects the maintenance of cytochrome 
P450-mediated biotransformation capacity 
and the longevity of the cells (Henkens et al., 
2007). Because of these results, the same in 
vitro system was used to investigate whether 
this higher functionality is also associated 
with effects on drug uptake transporters. As 
such freshly isolated rat hepatocytes were 
cultured in a conventional monolayer con-
figuration either in the absence or presence 
of 25 µM TSA for 4 days. Since DMSO (i.e. 
the TSA solvent) is known to favour the 
maintenance of the differentiated phenotype 
of primary hepatocytes (Isom et al., 1985), a 
number of cultures were separately treated 
with 0.083 % v/v DMSO, being the concen-
tration used as TSA solvent. RT-qPCR anal-
ysis was performed on T4 and D4 hepatocyte 
samples using B2m, Gapdh, Hmbs and Ubc 
as a combination of housekeeping genes for 
normalization (Figure 1). The mRNA levels 
of the uptake transporters Ntcp (p=0.037) 
and Oatp4 (p=0.015) significantly dropped 
as a function of the cultivation time in un-
treated hepatocytes. Furthermore, no clear 
effect of TSA or DMSO could be seen at 
both timepoints for the investigated trans-
porters.  
 
The effect of TSA on the protein expression 
of drug uptake transporters in primary rat 
hepatocyte cultures 
In order to investigate whether the find-
ings at the mRNA level are translated into 
similar protein modifications, semi-quanti-
tative immunoblot analyses were performed 
on whole cell lysates, using Hnf-1α as a 
housekeeping protein (Figures 2a and b). 
The significant downregulation in Ntcp 
(p=0.023) and Oatp4 (p=0.031) expression 
as a function of the cultivation time, ob-
served by RT-qPCR analysis, was confirmed 
by immunoblot analysis and no significant 
effects of TSA or DMSO could be seen at 
both timepoints for the investigated trans-
porters. 
 
The effect of TSA on the activity of drug 
uptake transporters in primary rat  
hepatocyte cultures 
To provide a complete picture of poten-
tial effects of TSA on uptake transporters in 
primary hepatocyte cultures, a number of ac-
tivity assays were performed. In this respect, 
intracellular accumulation of radiolabelled 
substrates of Oatp4 ([3H] estrone-3-sulfate) 
and Ntcp ([3H] taurocholic acid) was as-
sessed, both in the presence and absence of 
drug inhibitors, probenicid and sodium chlo-
ride, respectively. Results are presented as 
uptake of 1 µCi/ ml [3H] taurocholic acid 
and [3H] estrone-3-sulfate after 90 seconds 
incubation. The uptake of both substrates at 
that specific concentration was shown to be 
linear over this time range (supplementary 
Figures 1 and 2). 
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Figure 1: The effect of TSA on the mRNA expression 
level of drug uptake transporters in primary rat 
hepatocyte cultures. Freshly isolated rat hepatocytes 
were cultivated in 6 cm diameter dishes (19.5 cm2) as 
described in “2.2 Hepatocyte isolation and cultivation”. 
Hepatocyte samples were taken 4 hours after cell plat-
ing (T4) and at day 4 of the cultivation period (D4). 
Samples were subjected to RT-qPCR analysis, using 
B2m, Gapdh, Hmbs, Ubc as a combination of house-
keeping genes for normalization. Data are expressed 
as mean ± standard deviation of 3 independent exper-
iments and normalized to the mRNA level of T4 un-
treated hepatocytes (arbitrarily set at 100 %, indicated 
with a dotted line). Statistical analyses were performed 
using a 2-tailed paired Student’s t-test with p value ≤ 
0.05 considered to be significantly different. $p<0.05 
when D4 untreated hepatocytes are compared with T4 
counterparts. Samples collected 4 hours after cell plat-
ing are indicated with a gray bar and 4-day old cul-
tured hepatocytes with a white bar. (D4, day 4 cul-
tures; DMSO, dimethylsulfoxide; Nctp, sodium tau-
rocholate cotransporting polypeptide; Oatp4, organic 
anion transporting polypeptide 4; T4, 4 hours cultures; 
TSA, Trichostatin A) 
 
The intracellular accumulation of the ra-
dioactive substrates underwent a clear down-
regulation in the presence of the respective 
inhibitors, indicating the proper functioning 
of Ntcp and Oatp4 in the 3 cultivation condi-
tions at both timepoints (Figure 3a). Howev-
er, the smaller inhibitory effect observed in 
D4 cultures compared to T4 cultures sug-
gests reduced transporter functionality at this 
timepoint. Indeed, Ntcp and Oatp4 activity, 
represented by the difference in accumula-
tion in the absence and presence of the corre-
sponding inhibitor, was significantly de-
creased as a function of cultivation time. No 
effects related to the use of DMSO were seen 
at both timepoints. Only in T4 cultures, low-
er Oatp4 functionality (p=0.029) was ob-
served in TSA-treated versus DMSO-treated 
hepatocytes (Figure 3b).  
 
DISCUSSION 
The current study was set up to investi-
gate whether TSA, a HDAC inhibitor earlier 
shown in our laboratory to maintain cyto-
chrome P450-mediated biotransformation 
competence in primary cultured rat hepato-
cytes (Henkens et al., 2007), also affects 
drug transporter-mediated phase 0 metabo-
lism. Focus was hereby put on the sinusoidal 
uptake transporters Ntcp and Oatp4. When 
seeded in a conventional monolayer configu-
ration, canalicular drug transporter mRNA 
levels in primary cultured rat hepatocytes are 
usually better maintained in comparison with 
their basolateral counterparts (Jigorel et al., 
2005; Luttringer et al., 2002; Rippin et al., 
2001). In analogy with previous reports, 
downregulated mRNA expressions were ob-
served for Ntcp and Oatp4 as a function of 
the cultivation time. Regarding TSA, no sig-
nificant differences could be noticed in 
transporter mRNA quantities of TSA-treated 
and DMSO-treated monolayer cultures. Con-
sequently, TSA does not seem to affect he-
patic drug transporter gene expression, at 
least not in this type of in vitro system.  
Protein expression of drug transporters in 
conventional monolayer cultures has in gen-
eral not been extensively investigated. In this 
study, the detected translational modulations 
comply with the observed variations in 
mRNA expression levels. As previously de-
scribed (Liu et al., 1998; Rippin et al., 2001), 
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(a) 
 
(b)
 
 
Figure 2: The effect of TSA on the protein expression 
levels of drug uptake transporters in primary rat 
hepatocyte cultures. Freshly isolated rat hepatocytes 
were cultivated in 6 cm diameter dishes (19.5 cm2) as 
described in “2.2 Hepatocyte isolation and cultivation”. 
(a) Samples were taken 4 hours after cell plating (T4) 
and at day 4 of the cultivation period (D4) and subject-
ed to Western blot analysis. Results of 3 independent 
experiments are shown. (b) Densitometric analysis of 
the expression of drug transporters. Transporter sig-
nals were normalized against the corresponding Hnf-
1α signals and were expressed as a percentage of the 
normalized transporter signals in T4 untreated hepato-
cytes (arbitrarily set at 100 %, indicated with a dotted 
line). The results are shown as mean ± standard devi-
ation of 3 independent experiments. Statistical anal-
yses were performed using a 2-tailed paired Student’s 
t-test with p values ≤ 0.05 considered to be significant-
ly different. $p<0.05 when D4 untreated hepatocytes 
are compared with T4 counterparts. Samples collected 
4 hours after cell plating are indicated with a gray bar 
and 4-day old cultured hepatocytes with a white bar. 
(CD4, untreated hepatocytes D4; CT4, untreated 
hepatocytes T4; D4, day 4 cultures; DD4, DMSO-
treated hepatocytes D4; DMSO, dimethylsulfoxide; 
DT4, DMSO-treated hepatocytes T4; Nctp, sodium 
taurocholate cotransporting polypeptide; Oatp4, organ-
ic anion transporting polypeptide 4; T4, 4 hours cul-
tures; TD4, TSA-treated hepatocytes D4; TSA, Tri-
chostatin A; TT4, TSA-treated hepatocytes T4) 
 
 
Ntcp protein expression levels significantly 
decrease as a function of the cultivation time. 
A similar regulation was observed for Oatp4. 
To the best of our knowledge, no other re-
ports on Oatp4 protein expression in conven-
tional monolayer cultures have yet been pub-
lished. In line with other studies (Jigorel et 
al., 2005; Liu et al., 1998; Rippin et al., 
2001), the activities of Ntcp and Oatp4 
strongly declined with cultivation time. In 
general, DMSO had no effect on the expres-
sion and activity of the drug uptake trans-
porters studied. Nevertheless, positive effects 
of DMSO on hepatocellular Ntcp and Oatp 
drug transporters activity in primary hepato-
cyte cultures have already been described by 
others (Jigorel et al., 2005). It should be 
mentioned that in the current study, DMSO 
was used as the solvent for TSA and was 
kept as low as possible (0.083 % v/v). In the 
study of Isom and colleagues DMSO was 
present in much higher concentrations (2 % 
v/v) in order to reach an optimal mainte-
nance of the hepatocyte differentiated status 
(Isom et al., 1985).  
In conclusion, the epigenetic modifier 
TSA does not seem to exert an effect on the 
expression and activity of drug uptake trans-
porters in primary rat hepatocyte cultures 
although it clearly affected the metabolizing 
capacity (Henkens et al., 2007). Since it has 
been show that DNA methylation is involved 
in the liver-specific expression of the inves-
tigated drug transporters (Imai et al.,
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(a)        
(b)     
Figure 3: The effect of TSA on drug uptake transporter activity in primary rat hepatocyte cultures. Freshly isolated rat hepatocytes were cultivated in 6-well plates (9.6 cm2) as 
described in “2.2 Hepatocyte isolation and cultivation”. Hepatocyte cultures were incubated for 90 seconds with 1 µCi/ml radioactive substrate [3H] taurocholic acid (0.2 µM) 
(Ntcp) and [3H] estrone-3-sulfate (0.02 µM) (Oatp4) either in the presence or absence of their inhibitors, namely sodium ions (136 mM) (Ntcp) and probenecid (1 mM) (Oatp4), 
respectively. (a) Representation of intracellular accumulation in different experimental settings. The results were expressed as mean ± standard deviation of 4 independent ex-
periments and normalized for the intracellular accumulation measured in the untreated monolayer cultures in the absence of the respective inhibitor at T4 of cultivation (arbitrari-
ly set at 100 %, indicated with a dotted line). Statistical analyses were performed using a one-tailed paired Student’s t-test with p values ≤ 0.05 considered to be significantly dif-
ferent. #p≤0.05, when compared to substrate accumulation in the absence of an inhibitor (b) Transporter activity, equivalent to substrate uptake in the absence of the respective 
inhibitor minus the uptake in the presence of the inhibitor, is determined at T4 and D4 of cultivation for Ntcp and Oatp4. These results were expressed as mean ± standard de-
viation of 4 independent experiments with the transporter activity of untreated monolayers 4 hours after cell plating arbitrarily set at 100 %. Statistical analyses were performed 
using a 2-tailed paired Student’s t-test with p values ≤ 0.05 considered to be significantly different. $p≤0.05, when D4 transporter activity is compared with functionality in T4 un-
treated monolayer cultures; *p≤0.05, when TSA treated hepatocytes are compared with solvens control cultures. Samples collected 4 hours after cell plating are indicated with a 
gray bar and 4-day old cultured hepatocytes with a white bar. ([3H], tritium; D4, day 4 cultures; DMSO, dimethylsulfoxide; Nctp, sodium taurocholate cotransporting polypeptide; 
Oatp4, organic anion transporting polypeptide 4; T4, 4 hours cultures; TSA, Trichostatin A) 
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2009; Imai et al., 2013), it could be interest-
ing to study the effect of DNA methyltrans-
ferase (DNMT) as alternative epigenetic 
modulatory mechanism to improve drug 
transporter expression and activity in vitro. 
Furthermore, using a combination of epige-
netic modulators, namely HDACi and 
DNMT, could also be explored as it has al-
ready been demonstrated to have a synerget-
ic positive effect on the albumin secretory 
capacity of primary rat hepatocyte cultures 
(Fraczek et al., 2012). 
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